Peptides and Blood Pressure
Peptides and blood pressure: which approved peptides lower it, which raise it (PT-141, melanotan), and what users report. Not medical advice.
Anonymous user report. Not medical advice. Peptides discussed are not FDA-approved for the uses described. Editorial process →
Short answer
No peptide is approved primarily to treat high blood pressure. Weight-loss GLP-1 drugs tend to lower it modestly as weight falls. Some peptides raise it: bremelanotide (PT-141, Vyleesi) causes a temporary rise and is not for people with uncontrolled hypertension, and melanotan II is related. Growth-hormone peptides can cause fluid retention; the FDA has cited heart-rate and vasodilatory reactions with CJC-1295. Nothing here replaces blood-pressure medicine. Peptide Confessions does not publish dosing, timing, injection or sourcing guidance.
| Peptide | Effect on blood pressure |
|---|---|
| GLP-1 drugs | Often modest fall with weight loss |
| PT-141 (bremelanotide) | Temporary rise; label warning |
| Melanotan II | Flushing, possible rise |
| CJC-1295 | Heart-rate and vasodilatory reactions cited by FDA |
What users report
Heart-rate changes come up more than blood-pressure readings: #571 and #689 on growth-hormone peptides, and #120 after BPC-157 with TB-500. Chest pain, severe headache or a very high reading needs urgent care.
Related topics
community guides:
More confessions from the archive
Community Q&A
- Are there peptides that lower blood pressure?
- None is approved for that purpose. GLP-1 drugs often lower it modestly alongside weight loss.
- Does PT-141 raise blood pressure?
- Yes, temporarily. The Vyleesi label warns against use with uncontrolled hypertension or cardiovascular disease.
- Does Peptide Confessions give dosing?
- Peptide Confessions does not publish dosing, timing, injection or sourcing guidance.
Sources
Anonymous first-hand reports plus sourced context — educational only, not medical advice. Editorial policy & corrections.